Nordicus Partners Corporation (NORD)
OTCMKTS
· Delayed Price · Currency is USD
5.00
0.00 (0.00%)
May 6, 2025, 4:00 PM EDT
Nordicus Partners Revenue
Nordicus Partners had revenue of $2.50K in the quarter ending December 31, 2024. This brings the company's revenue in the last twelve months to $7.50K. In the fiscal year ending March 31, 2024, Nordicus Partners had annual revenue of $2.50K.
Revenue (ttm)
7.50K
Revenue Growth
n/a
P/S Ratio
11,508.26
Revenue / Employee
n/a
Employees
n/a
Market Cap
86.31M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 2.50K | - | - |
Mar 31, 2023 | - | - | - |
Mar 31, 2022 | - | - | - |
Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionNordicus Partners News
- 9 days ago - Nord Anglia Education's collaboration with IMG Academy creates exciting new opportunities for student performance, leadership, and wellbeing - Benzinga
- 5 weeks ago - Bio-Convert Receives Positive Feedback from The Danish Medicine Agency (DKMA) on its Lead Drug Candidate, QR-02 for Oral Leukoplakia - GlobeNewsWire
- 5 weeks ago - Orocidin's QR-01 Shows Positive Results in Treating Periodontitis in Dogs - GlobeNewsWire
- 2 months ago - Orocidin and Syngene Partner to Accelerate Biotech Innovation - GlobeNewsWire
- 2 months ago - Orocidin QR-01 Shows a Good Safety Profile in Preclinical Toxicity Study - GlobeNewsWire
- 3 months ago - Bio-Convert Develops QR-02, a Potential Breakthrough in the Treatment of Oral Leukoplakia - GlobeNewsWire
- 3 months ago - Oricidin Launches Groundbreaking Dental Gel for Long-Term Periodontitis Treatment - GlobeNewsWire
- 4 months ago - Nordicus Partners Corporation Announces Key Milestone in Development of Orocidin's Breakthrough Treatment for Periodontitis - GlobeNewsWire